Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model

Tamie Takenami, Saburo Yagishita, Yoshihiro Nara, Sumio Hoka

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Histologic evidence of the comparative neurotoxicity of lidocaine, mepivacaine, and prilocaine is incomplete. We compared the intrathecal neurotoxicity in rats among these 3 drugs based on morphologic and neurofunctional findings. Rats (n = 169) randomly received 0.12 μL/g of 0%, 2%, 5%, 7.5%, 10%, or 20% lidocaine, mepivacaine, or prilocaine or 25% glucose dissolved in distilled water via a chronically implanted intrathecal catheter. The effect of the agents on neurofunction was evaluated by movement of the hind limb (behavior test) and by sensory threshold (paw-stimulation test). The L1 spinal cord, the posterior and anterior roots, and the cauda equina were removed en bloc 5 days later and examined by light and electron microscopy. A significant decrease in sensory threshold or irreversible hind-limb limitation was observed only in rats receiving 20% lidocaine. Morphologic abnormalities characterized by axonal degeneration were observed in rats receiving ≥7.5% lidocaine, 20% mepivacaine, and 20% prilocaine, at the posterior white matter and the proximal portion of the posterior root just at the entrance into the spinal cord. The incidence of lesions was significantly higher in rats receiving lidocaine than mepivacaine and prilocaine. It is suggested that intrathecal mepivacaine and prilocaine are less neurotoxic than highly concentrated lidocaine in a rat intrathecal model.

Original languageEnglish
Pages (from-to)446-453
Number of pages8
JournalRegional Anesthesia and Pain Medicine
Volume29
Issue number5
DOIs
Publication statusPublished - Sep 1 2004

Fingerprint

Prilocaine
Mepivacaine
Lidocaine
Sensory Thresholds
Spinal Cord
Extremities
Cauda Equina
Electron Microscopy
Catheters
Light
Glucose
Water
Incidence
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model. / Takenami, Tamie; Yagishita, Saburo; Nara, Yoshihiro; Hoka, Sumio.

In: Regional Anesthesia and Pain Medicine, Vol. 29, No. 5, 01.09.2004, p. 446-453.

Research output: Contribution to journalArticle

Takenami, Tamie ; Yagishita, Saburo ; Nara, Yoshihiro ; Hoka, Sumio. / Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model. In: Regional Anesthesia and Pain Medicine. 2004 ; Vol. 29, No. 5. pp. 446-453.
@article{eb3f417832404dbdbdc4f158f03ee14f,
title = "Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model",
abstract = "Histologic evidence of the comparative neurotoxicity of lidocaine, mepivacaine, and prilocaine is incomplete. We compared the intrathecal neurotoxicity in rats among these 3 drugs based on morphologic and neurofunctional findings. Rats (n = 169) randomly received 0.12 μL/g of 0{\%}, 2{\%}, 5{\%}, 7.5{\%}, 10{\%}, or 20{\%} lidocaine, mepivacaine, or prilocaine or 25{\%} glucose dissolved in distilled water via a chronically implanted intrathecal catheter. The effect of the agents on neurofunction was evaluated by movement of the hind limb (behavior test) and by sensory threshold (paw-stimulation test). The L1 spinal cord, the posterior and anterior roots, and the cauda equina were removed en bloc 5 days later and examined by light and electron microscopy. A significant decrease in sensory threshold or irreversible hind-limb limitation was observed only in rats receiving 20{\%} lidocaine. Morphologic abnormalities characterized by axonal degeneration were observed in rats receiving ≥7.5{\%} lidocaine, 20{\%} mepivacaine, and 20{\%} prilocaine, at the posterior white matter and the proximal portion of the posterior root just at the entrance into the spinal cord. The incidence of lesions was significantly higher in rats receiving lidocaine than mepivacaine and prilocaine. It is suggested that intrathecal mepivacaine and prilocaine are less neurotoxic than highly concentrated lidocaine in a rat intrathecal model.",
author = "Tamie Takenami and Saburo Yagishita and Yoshihiro Nara and Sumio Hoka",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.rapm.2004.06.013",
language = "English",
volume = "29",
pages = "446--453",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Intrathecal mepivacaine and prilocaine are less neurotoxic than lidocaine in a rat intrathecal model

AU - Takenami, Tamie

AU - Yagishita, Saburo

AU - Nara, Yoshihiro

AU - Hoka, Sumio

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Histologic evidence of the comparative neurotoxicity of lidocaine, mepivacaine, and prilocaine is incomplete. We compared the intrathecal neurotoxicity in rats among these 3 drugs based on morphologic and neurofunctional findings. Rats (n = 169) randomly received 0.12 μL/g of 0%, 2%, 5%, 7.5%, 10%, or 20% lidocaine, mepivacaine, or prilocaine or 25% glucose dissolved in distilled water via a chronically implanted intrathecal catheter. The effect of the agents on neurofunction was evaluated by movement of the hind limb (behavior test) and by sensory threshold (paw-stimulation test). The L1 spinal cord, the posterior and anterior roots, and the cauda equina were removed en bloc 5 days later and examined by light and electron microscopy. A significant decrease in sensory threshold or irreversible hind-limb limitation was observed only in rats receiving 20% lidocaine. Morphologic abnormalities characterized by axonal degeneration were observed in rats receiving ≥7.5% lidocaine, 20% mepivacaine, and 20% prilocaine, at the posterior white matter and the proximal portion of the posterior root just at the entrance into the spinal cord. The incidence of lesions was significantly higher in rats receiving lidocaine than mepivacaine and prilocaine. It is suggested that intrathecal mepivacaine and prilocaine are less neurotoxic than highly concentrated lidocaine in a rat intrathecal model.

AB - Histologic evidence of the comparative neurotoxicity of lidocaine, mepivacaine, and prilocaine is incomplete. We compared the intrathecal neurotoxicity in rats among these 3 drugs based on morphologic and neurofunctional findings. Rats (n = 169) randomly received 0.12 μL/g of 0%, 2%, 5%, 7.5%, 10%, or 20% lidocaine, mepivacaine, or prilocaine or 25% glucose dissolved in distilled water via a chronically implanted intrathecal catheter. The effect of the agents on neurofunction was evaluated by movement of the hind limb (behavior test) and by sensory threshold (paw-stimulation test). The L1 spinal cord, the posterior and anterior roots, and the cauda equina were removed en bloc 5 days later and examined by light and electron microscopy. A significant decrease in sensory threshold or irreversible hind-limb limitation was observed only in rats receiving 20% lidocaine. Morphologic abnormalities characterized by axonal degeneration were observed in rats receiving ≥7.5% lidocaine, 20% mepivacaine, and 20% prilocaine, at the posterior white matter and the proximal portion of the posterior root just at the entrance into the spinal cord. The incidence of lesions was significantly higher in rats receiving lidocaine than mepivacaine and prilocaine. It is suggested that intrathecal mepivacaine and prilocaine are less neurotoxic than highly concentrated lidocaine in a rat intrathecal model.

UR - http://www.scopus.com/inward/record.url?scp=4544285806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544285806&partnerID=8YFLogxK

U2 - 10.1016/j.rapm.2004.06.013

DO - 10.1016/j.rapm.2004.06.013

M3 - Article

C2 - 15372390

AN - SCOPUS:4544285806

VL - 29

SP - 446

EP - 453

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 5

ER -